PRL-3 As Genetic Switch in Triple-Negative Breast Cancer (IMAGE)

University of Colorado Anschutz Medical Campus

PRL-3 As Genetic Switch in Triple-Negative Breast Cancer

Caption

University of Colorado Cancer Center investigators unpack the mechanism of investigational drug, AMPI-109, to show its inactivation of PRL-3 flips an important switch on triple-negative breast cancer.

Credit

University of Colorado Cancer Center

Usage Restrictions

With attribution

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.